British Skull Base Society Consensus on Vestibular Schwannoma Surveillance.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sethi Mantegh, Borsetto Daniele, Tysome James, Buttimore Juliette, Gamazo Nicola, Mannion Richard, Guilfoyle Matthew, Bance Manohar, Obholzer Rupert, Das Tilak, Scoffings Dan, Minett Thais, Jones Jonathan, Joshi Yogish, Scott Francis, Matys Tomasz, Freeman Simon, Lloyd Simon, Rutherford Scott, Potter Gillian, Siripurapu Rekha, Abdulla Sarah, Laitt Roger, Saloojee Ziyad, Summers David, Saeed Shakeel R, Bandino Fabrizio, MacKeith Samuel, Jeyaretna Sanjeeva, Philpott Carl, Shah Jagrit, Robertson Iain, Thomas Sebastian, Hattangadi Nameet, Paluzzi Alessandro, Kay Andrew, Awan Bushra, Rhys Rhian, Muthu Senthil, Clamp Philip J, Nannapaneni Ravi, Hayhurst Caroline, Gurusinghe Nihal, Alalade Andrew, Gilkes Catherine, Munir Nazia, Yousseff Ahmed, Patel Parag, Hampton Susanne, Hammerbeck-Ward Charlotte, Saunders Nick, Irving Richard, Monksfield Peter, Thomas Nicholas, Kitchen Neil, Barazi Sinan, Maratos Eleni, Connor Steve, Leonard Colin, Dawe Nicholas, Mohamed Hassan, Axon Patrick, Donnelly Neil
Аннотация
METHODS: In July 2022, a multi-disciplinary Delphi consensus was conducted at the British Skull Base Society Meeting. Expert United Kingdom-based skull-base surgeons and neuroradiologists were presented semi-systematic literature reviews summarizing current evidence on VS management. Anonymized opinions were collated and discussed to reach a majority vote, which was deemed the final consensus opinion.
RESULTS: Recommendations for VS managed by surveillance are: (1) surveillance frequency should decrease over time; (2) surveillance may be discontinued when the remaining lifetime risk of VS growth is <0.5% (∼8.5 years); (3) factors such as age, VS size, VS location, and cystic components should be considered. Surveillance after surgery or radiotherapy has limited evidence but recommendations are: (4) surveillance should be adjusted based on residual tumor size or nodular enhancement. Imaging modality and sequences are recommended to be (5) high-resolution magnetic resonance imaging with T1, T2, FIESTA/CISS multiplanar sequences, contrast is not required in untreated cases, and linear reporting of measurements is pragmatically sufficient.
CONCLUSION: This consensus and literature review provides an evidence and expert opinion-based guide to help clinicians with the surveillance of patients with VS. Further research should focus on better understanding the dynamic nature of growth risks and the growth characteristics of postintervention VS to enable personalized growth risk stratification.